Literature DB >> 2899661

Lytic anti-endothelial cell antibodies in haemolytic-uraemic syndrome.

D Y Leung1, J L Moake, P L Havens, M Kim, J S Pober.   

Abstract

Sera from 13 of 14 children with acute haemolytic uraemic syndrome (HUS) contained complement-fixing IgG and IgM antibodies that lysed cultured human umbilical vein endothelial cells. In 3 of 3 sera tested, no lysis of dermal fibroblasts was observed. The endothelial cell antigen was lost after treatment of the cells with gamma interferon. In contrast, only 3 of 5 adult patients with acute, non-relapsing, thrombotic thrombocytopenic purpura (TTP) had lytic anti-endothelial antibodies and only 1 of these recognised an antigen lost upon gamma interferon treatment. None of 32 control sera contained lytic anti-endothelial cell antibodies. These data suggest that HUS involves a disorder of immunoregulation and that a unique class of anti-endothelial cell antibodies is produced that may take part in the pathogenesis of vascular injury in HUS.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2899661     DOI: 10.1016/s0140-6736(88)92287-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  32 in total

1.  Modulation of eicosanoid metabolism in endothelial cells in a xenograft model. Role of cyclooxygenase-2.

Authors:  M Bustos; T M Coffman; S Saadi; J L Platt
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 2.  Glomerular fibrin deposition and removal.

Authors:  J M Bergstein
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

Review 3.  Anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies.

Authors:  M J Dillon; E J Tizard
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

Review 4.  Drug-induced thrombotic microangiopathy: incidence, prevention and management.

Authors:  R Pisoni; P Ruggenenti; G Remuzzi
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

5.  Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies.

Authors:  C O Savage; B E Pottinger; G Gaskin; C M Lockwood; C D Pusey; J D Pearson
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

6.  Verotoxigenic (enterohaemorrhagic) Escherichia coli in infants and toddlers in Czechoslovakia.

Authors:  M Bielaszewská; L Srámková; J Janda; K Bláhová; H Ambrozová
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

Review 7.  Functional properties of antiendothelial cell antibodies.

Authors:  A Kollmeier; M Kreditor; J George; Y Levy; Y Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 8.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

9.  A western blot assay detects autoantibodies to cryptic endothelial antigens in thrombotic microangiopathies.

Authors:  D W Koenig; L Barley-Maloney; T O Daniel
Journal:  J Clin Immunol       Date:  1993-05       Impact factor: 8.317

10.  Anti-endothelial cell antibodies in nephropathia epidemica and other viral diseases.

Authors:  A G Wangel; M Temonen; M Brummer-Korvenkontio; A Vaheri
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.